Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023) | McDonnell Boehnen Hulbert & Berghoff LLP
In those (in retrospect) halcyon days more than a decade ago (before Mayo, Myriad, Alice, and the subject matter eligibility quagmire arose), perhaps the most significant Supreme Court...
Sanofi Aventis Deutschland Gmb Bayer Schering Pharma Teleflex Inc Mylan Pharmaceuticals Google Inc Pro Stage Gear
Source: jdsupra.com